0
     

Report Added
Report already added
Glaucoma Surgery Devices Market by Surgery Type (Conventional Glaucoma Surgeries, Minimally Invasive Glaucoma Surgeries), Product (Glaucoma Drainage Devices, Glaucoma Laser Devices, Implants & Stents), End User (Eye Hospitals, Ophthalmology Clinics, Outpatient Surgical Centers)- Global Opportunity Analysis and Industry Forecast, 2020 - 2030

Glaucoma Surgery Devices Market by Surgery Type (Conventional Glaucoma Surgeries, Minimally Invasive Glaucoma Surgeries), Product (Glaucoma Drainage Devices, Glaucoma Laser Devices, Implants & Stents), End User (Eye Hospitals, Ophthalmology Clinics, Outpatient Surgical Centers)- Global Opportunity Analysis and Industry Forecast, 2020 - 2030

Market Definition:

The Global Glaucoma Surgery Devices Market size was valued at USD 786.5 million in 2019 is predicted to garner USD 7.97 billion by 2030, with a CAGR of 23.6% from 2020-2030.

Glaucoma is an ocular disease that affects the optic nerve of the iris diaphragm, and progression of the same results in optic nerve damage or vision loss. In glaucoma, intraocular pressure build-up within the eye due to excessive accumulation of eye-fluid; this may lead to eye-sight damage or blindness. According to the World Health Organization (WHO), glaucoma is the major cause of blindness, specifically in people aged over 60 years, across the globe.

Glaucoma surgery devices play a vital role while operating the patients suffering from glaucoma, hence are adopted on a large scale world-wide. These include various Lasik and non-Lasik implants as well as other such devices that help in reducing the intraocular pressure, thereby leveraging the ocular pressure. In the treatment of glaucoma, optical surgeons either use conventional glaucoma surgeries or minimal invasive glaucoma surgeries.

Market Dynamics and Trends

About 2.7 million Americans ageing 40 years or above suffer from open-angle glaucoma disorder, 3.3 million are affected by blindness or low-vision, and more than 3 million Americans are living with glaucoma disease. The increasing prevalence of glaucoma at global level, as well as constantly multiplying number of geriatric populations world-wide are the key factors driving the growth of global glaucoma surgery devices market.

Furthermore, higher inclination towards minimal invasive surgeries, increasing consumer awareness regarding treatment of this disease, advancements in healthcare infrastructures, and innovative developments in the product technologies, are the factors anticipated in propelling the growth of the global glaucoma surgery devices market throughout the forecast period.

However, less awareness regarding glaucoma treatment in the underdeveloped countries, shortage of skilled medical professionals, and risk of post-operative complications associated with glaucoma surgeries are hampering the growth of the glaucoma surgery devices market.

-n contrary, factors such as, higher investments in R&D activities, increase in number of campaigns by government & non-government organization for spreading awareness regarding glaucoma treatment, and untapped market opportunities in the emerging economies, shall pave the way for lucrative opportunities in the global glaucoma surgery devices market in coming future.

Market Segmentations and Scope of the Study:

The glaucoma surgery devices market share has been analyzed based on surgery type, product, end user, and geography.

Based on surgery type, the market is segmented into conventional glaucoma surgeries and minimally invasive glaucoma surgeries. The product segment is further divided into glaucoma drainage devices, glaucoma laser devices, and implants & stents. Based on the end user, the market covers eye hospitals, ophthalmology clinics, and outpatient surgical centers. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America is anticipated to hold the highest glaucoma surgery devices market share throughout the forecast period owing to higher prevalence of glaucoma in this region, increasing adoption of technologically advanced devices for glaucoma surgeries, and better reimbursement facilities.

Asia-Pacific region shall witness an increasing glaucoma surgery devices market size owing to improvement in the healthcare facility and growing awareness about treatment options.

Competitive Landscape

Comprehensive competitive analysis and profiles of the major market players such as Ellex Medical Lasers Ltd., Abbott Laboratories, Johnson & Johnson, Alcon, Inc., Topcon Corporation, Glaukos Corporation, New World Medical, Inc., Bausch & Lomb, Inc., Lumenis Ltd., Allergan Plc, and others are provided in the glaucoma surgery devices market report.

An upsurge in R&D activities and advancement in product technologies along with new product launches by the key players, is leading the healthcare infrastructure to new heights, thereby creating lucrative opportunities in the global glaucoma surgery devices market.

For instance, in November 2019, Glaukos Corporation completed its acquisition over Avedro, Inc, resulting into the amalgamation of two highly complementary hybrid pharma & devices organizations. Where Galukos is a pioneer ophthalmic medical-technology & pharmaceutical company in the global glaucoma surgery devices market engrossed in the innovation of novel therapies for treatment of corneal disorders, glaucoma, and retinal diseases; Avedro is a chief commercial-stage ophthalmic medical-technology company engrossed in treating corneal ectatic disorders as well as in improving vision. This acquisition shall reinforce Glaukos’s global commercial sale, market-building, extensive clinical & regulatory infrastructure, and reimbursement expertise, with Averdo’s novel bio-activated pharmaceutical solutions and R&D activities.

Furthermore, in March 2020, Allergan Plc., now acquired by AbbVie Inc., announced that it has received FDA approval for its ‘DURYSTA,’ the bimatoprost implant (10 mcg) for intracameral administration. With this DURYSTA becomes the first-ever ‘intracameral, biodegradable sustained-release implant designated to lower the intraocular pressure in patients suffering from ocular hypertension or open-angle glaucoma. DURYSTA is capable of reducing the intraocular pressure by approximately 30%. Allergan is a leading pharmaceutical company ruling the global glaucoma surgery devices market from more than 70 years. With this milestone Allergen makes a hefty contribution for the glaucoma community, as well as provides a much-needed alternative for patients suffering from topical drops, OAG, OHT, or vision problems.

KEY MARKET SEGMENTS:

Global Glaucoma Surgery Devices Market – By Surgery Type

Conventional Glaucoma Surgeries

Minimally Invasive Glaucoma Surgeries

Global Glaucoma Surgery Devices Market – By Product

Glaucoma Drainage Devices

Glaucoma Laser Devices

Implants & Stents

Global Glaucoma Surgery Devices Market – By End User

Eye Hospitals
-phthalmology Clinics
-utpatient Surgical Centers

Global Glaucoma Surgery Devices Market –By Geography

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Rest of Europe

Asia-Pacific

China

India

Japan

Australia

South Korea

Rest of Asia-Pacific

Rest of World

Turkey

Saudi Arabia

South Africa

Brazil

Remaining countries
1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2. MARKET SNAPSHOT, 2019-2030 MILLION USD
2.1. MARKET SNAPSHOT
3. PORTER’S FIVE FORCE MODEL ANALYSIS
4. MARKET DYNAMICS
4.1. GROWTH DRIVERS
4.1.1 DRIVER 1
4.1.2 DRIVER 2
4.1.3 DRIVER 3
4.1.4 DRIVER 4
4.2. CHALLENGES
4.2.1 CHALLENGE 1
4.2.2 CHALLENGE 2
4.3. OPPORTUNITIES
4.3.1 OPPORTUNITY 1
4.3.2 OPPORTUNITY 2
5. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE
5.1. OVERVIEW
5.2. CONVENTIONAL GLAUCOMA SURGERIES
5.2.1 CONVENTIONAL GLAUCOMA SURGERIES MARKET, BY REGION
5.2.1.1 North America Conventional Glaucoma Surgeries Market, By Country
5.2.1.2 Europe Conventional Glaucoma Surgeries Market, By Country
5.2.1.3 Asia-Pacific Conventional Glaucoma Surgeries Market, By Country
5.2.1.4 Rest of World Conventional Glaucoma Surgeries Market, By Country
5.3. MINIMALLY INVASIVE GLAUCOMA SURGERIES
5.3.1 MINIMALLY INVASIVE GLAUCOMA SURGERIES MARKET, BY REGION
5.3.1.1 North America Minimally Invasive Glaucoma Surgeries Market, By Country
5.3.1.2 Europe Minimally Invasive Glaucoma Surgeries Market, By Country
5.3.1.3 Asia-Pacific Minimally Invasive Glaucoma Surgeries Market, By Country
5.3.1.4 Rest of World Minimally Invasive Glaucoma Surgeries Market, By Country
6. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT
6.1. OVERVIEW
6.2. GLAUCOMA DRAINAGE DEVICES
6.2.1 GLAUCOMA DRAINAGE DEVICES MARKET, BY REGION
6.2.1.1 North America Glaucoma Drainage Devices Market, By Country
6.2.1.2 Europe Glaucoma Drainage Devices Market, By Country
6.2.1.3 Asia-Pacific Glaucoma Drainage Devices Market, By Country
6.2.1.4 Rest of World Glaucoma Drainage Devices Market, By Country
6.3. GLAUCOMA LASER DEVICES
6.3.1 GLAUCOMA LASER DEVICES MARKET, BY REGION
6.3.1.1 North America Glaucoma Laser Devices Market, By Country
6.3.1.2 Europe Glaucoma Laser Devices Market, By Country
6.3.1.3 Asia-Pacific Glaucoma Laser Devices Market, By Country
6.3.1.4 Rest of World Glaucoma Laser Devices Market, By Country
6.4. IMPLANTS & STENTS
6.4.1 IMPLANTS & STENTS MARKET, BY REGION
6.4.1.1 North America Implants & Stents Market, By Country
6.4.1.2 Europe Implants & Stents Market, By Country
6.4.1.3 Asia-Pacific Implants & Stents Market, By Country
6.4.1.4 Rest of World Implants & Stents Market, By Country
7. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY END USER
7.1. OVERVIEW
7.2. EYE HOSPITALS
7.2.1 EYE HOSPITALS MARKET, BY REGION
7.2.1.1 North America Eye Hospitals Market, By Country
7.2.1.2 Europe Eye Hospitals Market, By Country
7.2.1.3 Asia-Pacific Eye Hospitals Market, By Country
7.2.1.4 Rest of World Eye Hospitals Market, By Country
7.3. HOME SETTINGS & AMBULATORY SURGICAL CENTERS
7.3.1 HOME SETTINGS & AMBULATORY SURGICAL CENTERS MARKET, BY REGION
7.3.1.1 North America Home Settings & Ambulatory Surgical Centers Market, By Country
7.3.1.2 Europe Home Settings & Ambulatory Surgical Centers Market, By Country
7.3.1.3 Asia-Pacific Home Settings & Ambulatory Surgical Centers Market, By Country
7.3.1.4 Rest of World Home Settings & Ambulatory Surgical Centers Market, By Country
7.4. OUTPATIENT SURGICAL CENTERS
7.4.1 OUTPATIENT SURGICAL CENTERS MARKET, BY REGION
7.4.1.1 North America Outpatient Surgical Centers Market, By Country
7.4.1.2 Europe Outpatient Surgical Centers Market, By Country
7.4.1.3 Asia-Pacific Outpatient Surgical Centers Market, By Country
7.4.1.4 Rest of World Outpatient Surgical Centers Market, By Country
8. GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1 NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE
8.2.2 NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT
8.2.3 NORTH AMERICA GLAUCOMA SURGERY DEVICES MARKET, BY END USER
8.2.4 NORTH AMERICA GLAUCOMA SURGERY DEVICES, MARKET BY COUNTRY
8.2.4.1 U.S.
8.2.4.1.1 U.S. Glaucoma Surgery Devices Market, By Surgery Type
8.2.4.1.2 U.S. Glaucoma Surgery Devices Market, By Product
8.2.4.1.3 U.S. Glaucoma Surgery Devices Market, By End User
8.2.4.2 Canada
8.2.4.2.1 Canada Glaucoma Surgery Devices Market, By Surgery Type
8.2.4.2.2 Canada Glaucoma Surgery Devices Market, By Product
8.2.4.2.3 Canada Glaucoma Surgery Devices Market, By End User
8.2.4.3 Mexico
8.2.4.3.1 Mexico Glaucoma Surgery Devices Market, By Surgery Type
8.2.4.3.2 Mexico Glaucoma Surgery Devices Market, By Product
8.2.4.3.3 Mexico Glaucoma Surgery Devices Market, By End User
8.3. EUROPE
8.3.1 EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE
8.3.2 EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT
8.3.3 EUROPE GLAUCOMA SURGERY DEVICES MARKET, BY END USER
8.3.4 EUROPE GLAUCOMA SURGERY DEVICES, MARKET BY COUNTRY
8.3.4.1 Germany
8.3.4.1.1 Germany Glaucoma Surgery Devices Market, By Surgery Type
8.3.4.1.2 Germany Glaucoma Surgery Devices Market, By Product
8.3.4.1.3 Germany Glaucoma Surgery Devices Market, By End User
8.3.4.2 UK
8.3.4.2.1 UK Glaucoma Surgery Devices Market, By Surgery Type
8.3.4.2.2 UK Glaucoma Surgery Devices Market, By Product
8.3.4.2.3 UK Glaucoma Surgery Devices Market, By End User
8.3.4.3 France
8.3.4.3.1 France Glaucoma Surgery Devices Market, By Surgery Type
8.3.4.3.2 France Glaucoma Surgery Devices Market, By Product
8.3.4.3.3 France Glaucoma Surgery Devices Market, By End User
8.3.4.4 Italy
8.3.4.4.1 Italy Glaucoma Surgery Devices Market, By Surgery Type
8.3.4.4.2 Italy Glaucoma Surgery Devices Market, By Product
8.3.4.4.3 Italy Glaucoma Surgery Devices Market, By End User
8.3.4.5 Spain
8.3.4.5.1 Spain Glaucoma Surgery Devices Market, By Surgery Type
8.3.4.5.2 Spain Glaucoma Surgery Devices Market, By Product
8.3.4.5.3 Spain Glaucoma Surgery Devices Market, By End User
8.3.4.6 Rest of Europe
8.3.4.6.1 Rest of Europe Glaucoma Surgery Devices Market, By Surgery Type
8.3.4.6.2 Rest of Europe Glaucoma Surgery Devices Market, By Product
8.3.4.6.3 Rest of Europe Glaucoma Surgery Devices Market, By End User
8.4. ASIA-PACIFIC
8.4.1 ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE
8.4.2 ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT
8.4.3 ASIA-PACIFIC GLAUCOMA SURGERY DEVICES MARKET, BY END USER
8.4.4 ASIA-PACIFIC GLAUCOMA SURGERY DEVICES, MARKET BY COUNTRY
8.4.4.1 China
8.4.4.1.1 China Glaucoma Surgery Devices Market, By Surgery Type
8.4.4.1.2 China Glaucoma Surgery Devices Market, By Product
8.4.4.1.3 China Glaucoma Surgery Devices Market, By End User
8.4.4.2 India
8.4.4.2.1 India Glaucoma Surgery Devices Market, By Surgery Type
8.4.4.2.2 India Glaucoma Surgery Devices Market, By Product
8.4.4.2.3 India Glaucoma Surgery Devices Market, By End User
8.4.4.3 Japan
8.4.4.3.1 Japan Glaucoma Surgery Devices Market, By Surgery Type
8.4.4.3.2 Japan Glaucoma Surgery Devices Market, By Product
8.4.4.3.3 Japan Glaucoma Surgery Devices Market, By End User
8.4.4.4 Australia
8.4.4.4.1 Australia Glaucoma Surgery Devices Market, By Surgery Type
8.4.4.4.2 Australia Glaucoma Surgery Devices Market, By Product
8.4.4.4.3 Australia Glaucoma Surgery Devices Market, By End User
8.4.4.5 South Korea
8.4.4.5.1 South Korea Glaucoma Surgery Devices Market, By Surgery Type
8.4.4.5.2 South Korea Glaucoma Surgery Devices Market, By Product
8.4.4.5.3 South Korea Glaucoma Surgery Devices Market, By End User
8.4.4.6 Rest of Asia-Pacific
8.4.4.6.1 Rest of Asia-Pacific Glaucoma Surgery Devices Market, By Surgery Type
8.4.4.6.2 Rest of Asia-Pacific Glaucoma Surgery Devices Market, By Product
8.4.4.6.3 Rest of Asia-Pacific Glaucoma Surgery Devices Market, By End User
8.5. REST OF WORLD
8.5.1 REST OF WORLD GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE
8.5.2 REST OF WORLD GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT
8.5.3 REST OF WORLD GLAUCOMA SURGERY DEVICES MARKET, BY END USER
8.5.4 REST OF WORLD GLAUCOMA SURGERY DEVICES, MARKET BY COUNTRY
8.5.4.1 Brazil
8.5.4.1.1 Brazil Glaucoma Surgery Devices Market, By Surgery Type
8.5.4.1.2 Brazil Glaucoma Surgery Devices Market, By Product
8.5.4.1.3 Brazil Glaucoma Surgery Devices Market, By End User
8.5.4.2 Saudi Arabia
8.5.4.2.1 Saudi Arabia Glaucoma Surgery Devices Market, By Surgery Type
8.5.4.2.2 Saudi Arabia Glaucoma Surgery Devices Market, By Product
8.5.4.2.3 Saudi Arabia Glaucoma Surgery Devices Market, By End User
8.5.4.3 Turkey
8.5.4.3.1 Turkey Glaucoma Surgery Devices Market, By Surgery Type
8.5.4.3.2 Turkey Glaucoma Surgery Devices Market, By Product
8.5.4.3.3 Turkey Glaucoma Surgery Devices Market, By End User
8.5.4.4 South Africa
8.5.4.4.1 South Africa Glaucoma Surgery Devices Market, By Surgery Type
8.5.4.4.2 South Africa Glaucoma Surgery Devices Market, By Product
8.5.4.4.3 South Africa Glaucoma Surgery Devices Market, By End User
8.5.4.5 Remaining Countries
8.5.4.5.1 Remaining Countries Glaucoma Surgery Devices Market, By Surgery Type
8.5.4.5.2 Remaining Countries Glaucoma Surgery Devices Market, By Product
8.5.4.5.3 Remaining Countries Glaucoma Surgery Devices Market, By End User
9. COMPANY PROFILES
9.1. ALCON, INC.
9.1.1 COMPANY OVERVIEW
9.1.2 COMPANY SNAPSHOT
9.1.3 OPERATING BUSINESS SEGMENTS
9.1.4 PRODUCT PORTFOLIO
9.1.5 BUSINESS PERFORMANCE
9.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.2. GLAUKOS CORPORATION
9.2.1 COMPANY OVERVIEW
9.2.2 COMPANY SNAPSHOT
9.2.3 OPERATING BUSINESS SEGMENTS
9.2.4 PRODUCT PORTFOLIO
9.2.5 BUSINESS PERFORMANCE
9.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.3. NEW WORLD MEDICAL, INC
9.3.1 COMPANY OVERVIEW
9.3.2 COMPANY SNAPSHOT
9.3.3 OPERATING BUSINESS SEGMENTS
9.3.4 PRODUCT PORTFOLIO
9.3.5 BUSINESS PERFORMANCE
9.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.4. ELLEX MEDICAL LASERS LTD
9.4.1 COMPANY OVERVIEW
9.4.2 COMPANY SNAPSHOT
9.4.3 OPERATING BUSINESS SEGMENTS
9.4.4 PRODUCT PORTFOLIO
9.4.5 BUSINESS PERFORMANCE
9.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.5. ABBOTT MEDICAL OPTICS
9.5.1 COMPANY OVERVIEW
9.5.2 COMPANY SNAPSHOT
9.5.3 OPERATING BUSINESS SEGMENTS
9.5.4 PRODUCT PORTFOLIO
9.5.5 BUSINESS PERFORMANCE
9.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.6. JOHNSON & JOHNSON
9.6.1 COMPANY OVERVIEW
9.6.2 COMPANY SNAPSHOT
9.6.3 OPERATING BUSINESS SEGMENTS
9.6.4 PRODUCT PORTFOLIO
9.6.5 BUSINESS PERFORMANCE
9.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.7. BAUSCH & LOMB, INC.
9.7.1 COMPANY OVERVIEW
9.7.2 COMPANY SNAPSHOT
9.7.3 OPERATING BUSINESS SEGMENTS
9.7.4 PRODUCT PORTFOLIO
9.7.5 BUSINESS PERFORMANCE
9.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.8. TOPCON CORPORATION
9.8.1 COMPANY OVERVIEW
9.8.2 COMPANY SNAPSHOT
9.8.3 OPERATING BUSINESS SEGMENTS
9.8.4 PRODUCT PORTFOLIO
9.8.5 BUSINESS PERFORMANCE
9.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.9. LUMENIS LTD.
9.9.1 COMPANY OVERVIEW
9.9.2 COMPANY SNAPSHOT
9.9.3 OPERATING BUSINESS SEGMENTS
9.9.4 PRODUCT PORTFOLIO
9.9.5 BUSINESS PERFORMANCE
9.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.10. ALLERGAN PLC.
9.10.1 COMPANY OVERVIEW
9.10.2 COMPANY SNAPSHOT
9.10.3 OPERATING BUSINESS SEGMENTS
9.10.4 PRODUCT PORTFOLIO
9.10.5 BUSINESS PERFORMANCE
9.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT

Report Title: Glaucoma Surgery Devices Market by Surgery Type (Conventional Glaucoma Surgeries, Minimally Invasive Glaucoma Surgeries), Product (Glaucoma Drainage Devices, Glaucoma Laser Devices, Implants & Stents), End User (Eye Hospitals, Ophthalmology Clinics, Outpatient Surgical Centers)- Global Opportunity Analysis and Industry Forecast, 2020 - 2030


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline